Tell-Martí G - Search Results

1

Inherited MC1R variants in patients with melanoma are associated with better survival in women.

Lira FE, Podlipnik S, Potrony M, Tell-Martí G, Calbet-Llopart N, Barreiro A, Carrera C, Malvehy J, Puig S. Lira FE, et al. Br J Dermatol. 2020 Jan;182(1):138-146. doi: 10.1111/bjd.18024. Epub 2019 May 13. Br J Dermatol. 2020. PMID: 31016712 Free PMC article.

2

Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.

Puig-Butille JA, Escámez MJ, Garcia-Garcia F, Tell-Marti G, Fabra À, Martínez-Santamaría L, Badenas C, Aguilera P, Pevida M, Dopazo J, del Río M, Puig S. Puig-Butille JA, et al. Oncotarget. 2014 Mar 30;5(6):1439-51. doi: 10.18632/oncotarget.1444. Oncotarget. 2014. PMID: 24742402 Free PMC article.

3

The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.

Tell-Marti G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S. Tell-Marti G, et al. Ann Neurol. 2015 May;77(5):889-94. doi: 10.1002/ana.24373. Epub 2015 Mar 13. Ann Neurol. 2015. PMID: 25631192

4

Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma.

Carrera C, Puig-Butillè JA, Tell-Marti G, García A, Badenas C, Alós L, Puig S, Malvehy J. Carrera C, et al. JAMA Dermatol. 2015 May;151(5):544-8. doi: 10.1001/jamadermatol.2014.4115. JAMA Dermatol. 2015. PMID: 25651238 Free article.

5

Mutational status of naevus-associated melanomas.

Shitara D, Tell-Martí G, Badenas C, Enokihara MM, Alós L, Larque AB, Michalany N, Puig-Butille JA, Carrera C, Malvehy J, Puig S, Bagatin E. Shitara D, et al. Br J Dermatol. 2015 Sep;173(3):671-80. doi: 10.1111/bjd.13829. Epub 2015 Jun 19. Br J Dermatol. 2015. PMID: 25857817 Free PMC article.

6

Reply: To PMID 25631192.

Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S. Tell-Martí G, et al. Ann Neurol. 2015 Jul;78(1):153-4. doi: 10.1002/ana.24418. Epub 2015 May 25. Ann Neurol. 2015. PMID: 25913870 No abstract available.

7

Reply.

Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S. Tell-Martí G, et al. Ann Neurol. 2016 Jan;79(1):161-3. doi: 10.1002/ana.24526. Epub 2015 Dec 12. Ann Neurol. 2016. PMID: 26389780 No abstract available.

8

Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.

Potrony M, Puig-Butille JA, Aguilera P, Badenas C, Tell-Marti G, Carrera C, Javier Del Pozo L, Conejo-Mir J, Malvehy J, Puig S. Potrony M, et al. JAMA Dermatol. 2016 Apr;152(4):405-12. doi: 10.1001/jamadermatol.2015.4356. JAMA Dermatol. 2016. PMID: 26650189 Free article.

9

Reply.

Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S. Tell-Martí G, et al. Ann Neurol. 2016 May;79(5):868. doi: 10.1002/ana.24629. Epub 2016 Mar 22. Ann Neurol. 2016. PMID: 26934067 No abstract available.

10

Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas.

Potrony M, Badenas C, Naerhuyzen B, Aguilera P, Puig-Butille JA, Tell-Marti G, Díaz A, Carrera C, Alos L, Delahaye N, Malvehy J, Puig S. Potrony M, et al. Clin Chem Lab Med. 2016 Nov 1;54(11):1733-1738. doi: 10.1515/cclm-2015-1048. Clin Chem Lab Med. 2016. PMID: 27101548 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters